Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Short-Course Antimicrobial Therapy Does Not Increase Treatment Failure Rate in Patients with Intra-Abdominal Infection Involving Fungal Organisms.

Elwood NR, Guidry CA, Duane TM, Cuschieri J, Cook CH, O'Neill PJ, Askari R, Napolitano LM, Namias N, Dellinger EP, Watson CM, Banton KL, Blake DP, Hassinger TE, Sawyer RG.

Surg Infect (Larchmt). 2018 May/Jun;19(4):376-381. doi: 10.1089/sur.2017.235. Epub 2018 Mar 22.

PMID:
29565726
2.

Longer-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections.

Hassinger TE, Guidry CA, Rotstein OD, Duane TM, Evans HL, Cook CH, O'Neill PJ, Mazuski JE, Askari R, Napolitano LM, Namias N, Miller PR, Dellinger EP, Coimbra R, Cocanour CS, Banton KL, Cuschieri J, Popovsky K, Sawyer RG.

Surg Infect (Larchmt). 2017 Aug/Sep;18(6):659-663. doi: 10.1089/sur.2017.084. Epub 2017 Jun 26.

3.

Obesity Is Not Associated with Antimicrobial Treatment Failure for Intra-Abdominal Infection.

Dietch ZC, Duane TM, Cook CH, O'Neill PJ, Askari R, Napolitano LM, Namias N, Watson CM, Dent DL, Edwards BL, Shah PM, Guidry CA, Davies SW, Willis RN, Sawyer RG.

Surg Infect (Larchmt). 2016 Aug;17(4):412-21. doi: 10.1089/sur.2015.213. Epub 2016 Mar 30.

4.

Evaluation of a Short Course of Antimicrobial Therapy for Complicated Intra-Abdominal Infections in Critically Ill Surgical Patients.

Smith SE, Rumbaugh KA, May AK.

Surg Infect (Larchmt). 2017 Aug/Sep;18(6):742-750. doi: 10.1089/sur.2017.011.

PMID:
28832270
5.

Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.

Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Claridge JA, Cocanour CS, Coimbra R, Cook CH, Cuschieri J, Dellinger EP, Duane TM, Evans HL, Lipsett PA, Mazuski JE, Miller PR, O'Neill PJ, Rotstein OD, Namias N.

J Am Coll Surg. 2016 Apr;222(4):440-6. doi: 10.1016/j.jamcollsurg.2015.12.050. Epub 2016 Jan 14.

PMID:
26920994
6.

Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?

Shah PM, Edwards BL, Dietch ZC, Guidry CA, Davies SW, Hennessy SA, Duane TM, O'Neill PJ, Coimbra R, Cook CH, Askari R, Popovsky K, Sawyer RG.

Surg Infect (Larchmt). 2016 Feb;17(1):27-31. doi: 10.1089/sur.2015.127. Epub 2015 Sep 23.

7.

Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections.

Riccio LM, Popovsky KA, Hranjec T, Politano AD, Rosenberger LH, Tura KC, Sawyer RG.

Surg Infect (Larchmt). 2014 Aug;15(4):417-24. doi: 10.1089/sur.2012.077. Epub 2014 May 13.

8.

Essentials for selecting antimicrobial therapy for intra-abdominal infections.

Blot S, De Waele JJ, Vogelaers D.

Drugs. 2012 Apr 16;72(6):e17-32. doi: 10.2165/11599800-000000000-00000.

9.

Does Isolation of Enterococcus Affect Outcomes in Intra-Abdominal Infections?

Sanders JM, Tessier JM, Sawyer R, Dellinger EP, Miller PR, Namias N, West MA, Cook CH, O'Neill PJ, Napolitano L, Rattan R, Cuschieri J, Claridge JA, Guidry CA, Askari R, Banton K, Rotstein O, Moore BJ, Duane TM.

Surg Infect (Larchmt). 2017 Nov/Dec;18(8):879-885. doi: 10.1089/sur.2017.121. Epub 2017 Oct 10.

PMID:
28994635
10.

Trial of short-course antimicrobial therapy for intraabdominal infection.

Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O'Neill PJ, Mazuski JE, Askari R, Wilson MA, Napolitano LM, Namias N, Miller PR, Dellinger EP, Watson CM, Coimbra R, Dent DL, Lowry SF, Cocanour CS, West MA, Banton KL, Cheadle WG, Lipsett PA, Guidry CA, Popovsky K; STOP-IT Trial Investigators.

N Engl J Med. 2015 May 21;372(21):1996-2005. doi: 10.1056/NEJMoa1411162. Erratum in: N Engl J Med. 2018 Jan 25;:null.

11.

Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?

Hennessy SA, Shah PM, Guidry CA, Davies SW, Hranjec T, Sawyer RG.

Surg Infect (Larchmt). 2015 Aug;16(4):396-400. doi: 10.1089/sur.2014.211. Epub 2015 Jun 12.

12.

Antimicrobial Susceptibility Of Intra-Abdominal Infection Isolates From A Tertiary Care Hospital In Karachi.

Saad U, Anwar S, Kahara UZ, Siddiqui M, Hina H.

J Ayub Med Coll Abbottabad. 2016 Jul-Sep;28(3):568-571.

13.

Age and Its Impact on Outcomes with Intra-Abdominal Infection.

Farmer D, Tessier JM, Sanders JM, Sawyer RG, Rotstein OD, Dellinger EP, Lipsett PA, Cuschieri J, Miller P, Cook CH, Guidry CA, Askari R, Moore BJ, Duane TM.

Surg Infect (Larchmt). 2017 Feb/Mar;18(2):77-82. doi: 10.1089/sur.2016.184. Epub 2016 Dec 22.

PMID:
28005468
14.

Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.

Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE.

Surg Infect (Larchmt). 2015 Dec;16(6):785-93. doi: 10.1089/sur.2014.166. Epub 2015 Aug 10.

PMID:
26258265
15.

Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.

Mazuski JE.

Surg Infect (Larchmt). 2005;6 Suppl 2:S-49-69. Review.

PMID:
23577497
16.

Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.

Labricciosa FM, Sartelli M, Abbo LM, Barbadoro P, Ansaloni L, Coccolini F, Catena F.

Surg Infect (Larchmt). 2018 Apr;19(3):264-272. doi: 10.1089/sur.2017.217. Epub 2018 Jan 3.

PMID:
29298133
17.

Percutaneously drained intra-abdominal infections do not require longer duration of antimicrobial therapy.

Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Coimbra R, Cook CH, Duane TM, O ľNeill PJ, Rotstein OD, Namias N.

J Trauma Acute Care Surg. 2016 Jul;81(1):108-13. doi: 10.1097/TA.0000000000001019.

PMID:
26953758
18.

Intra-abdominal fungal infections.

Rebolledo M, Sarria JC.

Curr Opin Infect Dis. 2013 Oct;26(5):441-6. doi: 10.1097/01.qco.0000433309.21148.f7. Review.

PMID:
23982234
19.

Patients with Risk Factors for Complications Do Not Require Longer Antimicrobial Therapy for Complicated Intra-Abdominal Infection.

Rattan R, Allen CJ, Sawyer RG, Mazuski J, Duane TM, Askari R, Banton KL, Claridge JA, Coimbra R, Cuschieri J, Dellinger EP, Evans HL, Guidry CA, Miller PR, O'Neill PJ, Rotstein OD, West MA, Popovsky K, Namias N.

Am Surg. 2016 Sep;82(9):860-6.

PMID:
27670577
20.

Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.

Bartoletti M, Tedeschi S, Pascale R, Raumer L, Maraolo AE, Palmiero G, Tumietto F, Cristini F, Ambretti S, Giannella M, Lewis RE, Viale P.

Int J Antimicrob Agents. 2018 Mar;51(3):516-521. doi: 10.1016/j.ijantimicag.2018.01.010. Epub 2018 Feb 2.

PMID:
29410250

Supplemental Content

Support Center